Prokidney (PROK) Interest Coverage Ratio (2021 - 2026)
Prokidney's (PROK) quarterly Interest Coverage Ratio came in at 48373.0 in Q2 2026, down 21.82% year-over-year from 61872.88 in Q2 2025, and down 1514.84% quarter-over-quarter from 2995.53 in Q1 2026.
Powered by 
Analysis
Prokidney (PROK) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Interest Coverage Ratio for 6 consecutive years, with 48373.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 21.82% year-over-year to 48373.0 in Q2 2026; TTM through Jun 2026 was 9327.16, a 74.33% increase from a year earlier, with the FY2025 full-year figure at 41251.75, down 102.13% from the prior year.
- Interest Coverage Ratio was 48373.0 for Q2 2026 at Prokidney, down from 2995.53 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 121.99 in Q2 2022 and troughed at 48373.0 in Q2 2026.
- A 5-year average of 18620.71 and a median of 15117.5 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 92.82% in 2022 and tumbled 8060.42% in 2023, its largest moves.
- Over 5 years, Interest Coverage Ratio stood at 15117.5 in 2022, then soared by 46.62% to 8070.0 in 2023, then sank by 219.52% to 25785.5 in 2024, then sank by 75.96% to 45371.0 in 2025, then fell by 6.62% to 48373.0 in 2026.
- The last three Interest Coverage Ratio figures came in at 48373.0 (Q2 2026), 2995.53 (Q1 2026), and 45371.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 2.71 |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -48,373.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48,373.00 |
| Mar 31, 2026 | -2,995.53 |
| Dec 31, 2025 | -45,371.00 |
| Sep 30, 2025 | -19,269.50 |
| Jun 30, 2025 | -39,709.00 |
| Dec 31, 2024 | -25,785.50 |
| Sep 30, 2024 | -24,486.50 |
| Jun 30, 2024 | -14,352.00 |
| Mar 31, 2024 | -20,038.00 |
| Dec 31, 2023 | -8,070.00 |
| Sep 30, 2023 | -23,308.50 |
| Jun 30, 2023 | -9,954.75 |
| Mar 31, 2023 | -13,625.33 |
| Dec 31, 2022 | -15,117.50 |
| Sep 30, 2022 | -1,226.62 |
| Jun 30, 2022 | -121.99 |
| Mar 31, 2022 | -4,747.29 |
| Sep 30, 2021 | -17,081.00 |